Cargando…

Regadenoson as a pharmacologic stressor in cardiac magnetic resonance imaging in congenital and acquired pediatric heart disease: initial experience

Detalles Bibliográficos
Autores principales:	Noel, Cory V, Krishnamurthy, Ramkumar, Brady, Moffett, Krishnamurthy, Rajesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328312/ http://dx.doi.org/10.1186/1532-429X-17-S1-P211

Ejemplares similares

Myocardial T1 mapping as a diagnostic tool in pediatric patients with a concern for cardiac disease
por: Noel, Cory V, et al.
Publicado: (2016)

Comparison of Respiratory-Triggered (RT) 3D cine steady-state free precession cardiac mri with standard 2D cine imaging and magnetic resonance angiography in Congenital Heart Disease (CHD)
por: Atweh, Lamya A, et al.
Publicado: (2015)

Prospective comparison of circumferential and longitudinal strain in asymptomatic children with single left ventricle, single right ventricle and normal hearts
por: Noel, Cory, et al.
Publicado: (2014)

Comparison of myocardial rotation and torsion in asymptomatic children with single RV, single LV and normal hearts
por: Krishnamurthy, Ramkumar, et al.
Publicado: (2014)

Prospective evaluation of circumferential and longitudinal strain in asymptomatic children with dual ventricles who underwent single ventricle repair: comparison to single LV, single RV and normal hearts
por: Krishnamurthy, Ramkumar, et al.
Publicado: (2015)

Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance
por: Freed, Benjamin H, et al.
Publicado: (2013)

Effects of adenosine and regadenoson on hemodynamics measured using cardiovascular magnetic resonance imaging
por: Thomas, Dustin M., et al.
Publicado: (2017)

Ventricular coupling in single ventricle patients: a MRI study of cardiac biomechanics
por: Krishnamurthy, Ramkumar, et al.
Publicado: (2016)

Unsupervised free-breathing 3D imaging of morphology, function and flow in congenital heart disease
por: Krishnamurthy, Rajesh, et al.
Publicado: (2014)

Regadenoson cardiovascular magnetic resonance myocardial perfusion imaging predicts need for future revascularization
por: Freed, Benjamin H, et al.
Publicado: (2012)

Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson
por: Bhave, Nicole M, et al.
Publicado: (2012)

Inter -observer variability in manual measurement of aortic root dimensions in pediatric patients: benefits of using a semi-automated tool
por: Krishnamurthy, Ramkumar, et al.
Publicado: (2014)

SCMR expert consensus statement for cardiovascular magnetic resonance of acquired and non-structural pediatric heart disease
por: Dorfman, Adam L., et al.
Publicado: (2022)

The effect of obesity on regadenoson-induced myocardial hyperemia: a quantitative magnetic resonance imaging study
por: DiBella, Edward V. R., et al.
Publicado: (2011)

Safety and prognostic value of regadenoson stress cardiovascular magnetic resonance imaging in heart transplant recipients
por: Kazmirczak, Felipe, et al.
Publicado: (2019)

Unsupervised free-breathing 3-dimensional imaging of morphology, function and flow in congenital heart disease under 30 minutes: pilot study
por: Krishnamurthy, Rajesh, et al.
Publicado: (2014)

Safety and tolerability of regadenoson CMR
por: Nguyen, Kim-Lien, et al.
Publicado: (2014)

Multi-parametric cardiovascular magnetic resonance with regadenoson stress perfusion is safe following pediatric heart transplantation and identifies history of rejection and cardiac allograft vasculopathy
por: Husain, Nazia, et al.
Publicado: (2021)

Regadenoson administration and QT interval prolongation during pharmacological radionuclide myocardial perfusion imaging
por: Rafiq, Arsalan, et al.
Publicado: (2020)

Evaluation of a Subject specific dual-transmit approach for improving B(1) field homogeneity in cardiovascular magnetic resonance at 3T
por: Krishnamurthy, Ramkumar, et al.
Publicado: (2013)

Feasibility and preliminary diagnostic results of pixel-wise quantification of regadenoson first pass cardiac magnetic resonance perfusion imaging
por: Ta, Allison D, et al.
Publicado: (2014)

Regadenoson in the detection of coronary artery disease
por: Buhr, Christiane, et al.
Publicado: (2008)

Clinical validation of free breathing respiratory triggered retrospectively cardiac gated cine balanced steady-state free precession cardiovascular magnetic resonance in sedated children
por: Krishnamurthy, Rajesh, et al.
Publicado: (2015)

Editorial: Regadenoson: An adenosine A(2A) receptor agonist for pharmacological myocardial perfusion imaging
por: Matsuo, Shinro
Publicado: (2014)

Regadenoson in Europe: first-year experience of regadenoson stress combined with submaximal exercise in patients undergoing myocardial perfusion scintigraphy
por: Brinkert, M., et al.
Publicado: (2013)

Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole- a study of first pass quantitative perfusion cardiovascular magnetic resonance
por: Vasu, Sujethra, et al.
Publicado: (2013)

Cardiovascular magnetic resonance stress and rest T1-mapping using regadenoson for detection of ischemic heart disease compared to healthy controls
por: Burrage, Matthew K., et al.
Publicado: (2021)

Safety and Efficacy of Regadenoson for Pediatric Stress Perfusion Cardiac MRI with Quantification of Myocardial Blood Flow
por: Patel, Shivani G., et al.
Publicado: (2022)

Effects of caffeine intake prior to stress cardiac magnetic resonance perfusion imaging on regadenoson- versus adenosine-induced hyperemia as measured by T1 mapping
por: van Dijk, R., et al.
Publicado: (2017)

Stress perfusion cardiac MRI with regadenoson and gadofoveset trisodium
por: Allen, Bradley D, et al.
Publicado: (2015)

Seizure: An Adverse Effect of Regadenoson in Myocardial Perfusion Imaging
por: Radwan, Sohab S., et al.
Publicado: (2019)

Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: a prospective, randomized, multicenter study
por: Tejani, Furqan H., et al.
Publicado: (2014)

The Role of Cardiovascular Magnetic Resonance in Pediatric Congenital Heart Disease
por: Ntsinjana, Hopewell N, et al.
Publicado: (2011)

Serious complications associated with regadenoson administration for myocardial perfusion imaging
por: Kitt, Therese, et al.
Publicado: (2014)

Caffeine Consumption and Heart Rate and Blood Pressure Response to Regadenoson
por: Bitar, Abbas, et al.
Publicado: (2015)

Severe Shivering as an Adverse Effect of Regadenoson Myocardial Perfusion Imaging
por: Ahmad, Tanjeev, et al.
Publicado: (2021)

Safety, feasibility, and hemodynamic response of regadenoson for stress perfusion CMR
por: Muñiz-Sáenz-Diez, Javier, et al.
Publicado: (2023)

Quality Initiative to Reduce Cardiac CT Angiography Radiation Exposure in Patients with Congenital Heart Disease
por: Ali, Fatima, et al.
Publicado: (2019)

Initial results of a new very rapid rest/regadenoson stress myocardial perfusion protocol in patients with atrial fibrillation
por: Chang, Lowell, et al.
Publicado: (2014)

Time resolved measure of coronary sinus flow following regadenoson administration
por: Booker, O Julian, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_q2ndih3scrvq0200e7cesukea8